Related Experiment Video

Updated: Sep 5, 2025

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

15.1K

Targeting the transcriptional activity of STAT3 by a novel fusion protein

Yanqiong Chen1,2, Wenting Zhang1, Xiufeng Bai3,4

  • 1National Clinical Research Center for Geriatrics and Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Sichuan Province, Chengdu, 610041, China.

BMC Cancer
|July 9, 2022
PubMed
Abstract

Insights

Researchers developed a novel KRAB-STAT3 fusion protein to block the activity of Signal Transducer and Activator of Transcription 3 (STAT3). This targeted inhibition effectively suppressed tumor cell growth, offering a new therapeutic strategy for cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Development

Background:

  • Continuous activation of transcription factors, such as STAT3, is implicated in various diseases, including cancer, autoimmune disorders, neurodegenerative conditions, and male infertility.
  • Inhibiting the transcriptional activity of these key proteins presents a potential strategy to halt disease progression.

Purpose of the Study:

  • To develop a novel method for specifically inhibiting the transcriptional activity of the Signal Transducer and Activator of Transcription 3 (STAT3) protein.
  • To evaluate the efficacy of this inhibition in blocking STAT3's role in disease processes, particularly in cancer.

Main Methods:

  • A fusion protein was engineered by combining the transcriptional inhibitory domain KRAB with STAT3.
  • The functionality of the KRAB-STAT3 fusion protein was assessed in cancer cells, focusing on its impact on STAT3 transcriptional activity.
  • The study confirmed that the fusion protein specifically targeted STAT3's transcriptional function without disrupting its activity in cellular organelles like mitochondria and lysosomes.

Main Results:

  • The expression of the KRAB-STAT3 fusion protein was shown to effectively inhibit the growth of tumor cells.
  • This inhibition demonstrates the potential of targeting STAT3 activity to control neoplastic cell proliferation.

Conclusions:

  • The KRAB-STAT3 fusion protein represents a promising novel therapeutic target for drug development.
  • This approach offers a new avenue for treating cancers and autoimmune diseases driven by aberrant STAT3 signaling.
Keywords:
Autoimmune diseasesKRABMale infertilityNeurodegenerative diseasesSTAT3Transcriptioncancer

More Related Videos

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis10:22

Protein Purification-free Method of Binding Affinity Determination by Microscale Thermophoresis

Published on: August 15, 2013

30.8K
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.6K

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K